AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633
Open accessAbstract
Endothelial nitric oxide synthase (eNOS) plays a central role in maintaining cardiovascular homeostasis by controlling NO bioavailability. The activity of eNOS in vascular endothelial cells (ECs) largely depends on posttranslational modifications, including phosphorylation. Because the activity of AMP-activated protein kinase (AMPK) in ECs can be increased by multiple cardiovascular events, we studied the phosphorylation of eNOS Ser633 by AMPK and examined its functional relevance in the mouse models. Shear stress, atorvastatin, and adiponectin all increased AMPK Thr172 and eNOS Ser633 phosphorylations, which were abolished if AMPK was pharmacologically inhibited or genetically ablated. The constitutively active form of AMPK or an AMPK agonist caused a sustained Ser633 phosphorylation. Expression of gain-/loss-of-function eNOS mutants revealed that Ser633 phosphorylation is important for NO production. The aorta of AMPKalpha2(-/-) mice showed attenuated atorvastatin-induced eNOS phosphorylation. Nano-liquid chromatography/tandem mass spectrometry (LC/MS/MS) confirmed that eNOS Ser633 was able to compete with Ser1177 or acetyl-coenzyme A carboxylase Ser79 for AMPKalpha phosphorylation. Nano-LC/MS/MS confirmed that eNOS purified from AICAR-treated ECs was phosphorylated at both Ser633 and Ser1177. Our results indicate that AMPK phosphorylation of eNOS Ser633 is a functional signaling event for NO bioavailability in ECs.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
AMPK is essential in maintaining NO bioavailability.
“Increasing evidence suggests that AMPK is essential in maintaining NO bioavailability.”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [163]
AMPK acts as a direct activator of eNOS by phosphorylating its Ser1177 residue.
“AMPK is activated and in turn acts as a direct activator of eNOS by phosphorylating its Ser1177 residue [163].”
From AMPK, Mitochondrial Function, and Cardiovascular Disease (2020) · cites this paper as [163]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Furchgott, R. F., & Zawadzki, J. V. (1980) · Nature · doi:10.1038/288373a0 · Cited by 12,064 · see citing works
Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor
Palmer, R. M. J., Ferrige, A. G., & Moncada, S. (1987) · Nature · doi:10.1038/327524a0 · Cited by 10,704 · see citing works
Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation
Dimmeler, S., Fleming, I., Fisslthaler, B., Hermann, C., Busse, R., & Zeiher, A. M. (1999) · Nature · doi:10.1038/21224 · Cited by 3,591 · see citing works
Specificity and mechanism of action of some commonly used protein kinase inhibitors.
Davies, S., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/bj3510095 · Cited by 3,164 · see citing works
Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D. J., Gratton, J., McCabe, T. J. D., Fontana, J. T., Fujio, Y., Walsh, K. X., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/21218 · Cited by 2,585 · see citing works
Specificity and mechanism of action of some commonly used protein kinase inhibitors
Davies, S., Reddy, H., Caivano, M., & Cohen, P. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510095 · Cited by 1,618 · see citing works
AMP-Activated Protein Kinase in Metabolic Control and Insulin Signaling
Towler, M. C., & Hardie, D. G. (2007) · Circulation Research · doi:10.1161/01.res.0000256090.42690.05 · Cited by 1,248 · see citing works
Corton, J. M., Gillespie, J. G., Hawley, S. A., & Hardie, D. G. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.tb20498.x · Cited by 1,232 · see citing works
Endothelial Function: Cardiac Events
Lerman, A., & Zeiher, A. M. (2005) · Circulation · doi:10.1161/01.cir.0000153339.27064.14 · Cited by 1,096 · see citing works
Mammalian nitric oxide synthases
Stuehr, D. J. (1999) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(99)00016-x · Cited by 996 · see citing works
Adiponectin Stimulates Production of Nitric Oxide in Vascular Endothelial Cells
Chen, H., Montagnani, M., Funahashi, T., Shimomura, I., & Quon, M. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307878200 · Cited by 993 · see citing works
AMP‐activated protein kinase phosphorylation of endothelial NO synthase
Chen, Z.-P., Mitchelhill, K. I., Michell, B. J., Stapleton, D., Rodríguez‐Crespo, I., Witters, L. A., Power, D. A., de Montellano, P. R. O., & Kemp, B. E. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01705-0 · Cited by 835 · see citing works
Fleming, I., Fisslthaler, B., Dimmeler, S., Kemp, B. E., & Busse, R. (2001) · Circulation Research · doi:10.1161/hh1101.092677 · Cited by 770 · see citing works
Enzymatic function of nitric oxide synthases
Andrew, P. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(99)00115-7 · Cited by 755 · see citing works
Nitric Oxide Insufficiency, Platelet Activation, and Arterial Thrombosis
Loscalzo, J. (2001) · Circulation Research · doi:10.1161/hh0801.089861 · Cited by 612 · see citing works
Sessa, W. C. (2004) · Journal of Cell Science · doi:10.1242/jcs.01165 · Cited by 561 · see citing works
Michell, B. J., Chen, Z., Tiganis, T., Stapleton, D., Katsis, F., Power, D. A., Sim, A. T. R., & Kemp, B. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100122200 · Cited by 560 · see citing works
The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity
Viollet, B., Andreelli, F., Jørgensen, S. B., Perrin, C., Geloen, A., Flamez, D., Mu, J., Lenzner, C., Baud, O., Bennoun, M., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci16567 · Cited by 499 · see citing works
Regulation of endothelial and myocardial NO synthesis by multi-site eNOS phosphorylation
Mount, P. F., Kemp, B. E., & Power, D. A. (2007) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2006.05.023 · Cited by 498 · see citing works
Boo, Y. C., Sorescu, G. P., Boyd, N. L., Shiojima, I., Walsh, K., Du, J., & Jo, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108789200 · Cited by 447 · see citing works
Laderoute, K. R., Amin, K., Calaoagan, J. M., Knapp, M., Le, T., Orduna, J. M., Foretz, M., & Viollet, B. (2006) · Molecular and Cellular Biology · doi:10.1128/mcb.00166-06 · Cited by 443 · see citing works
DAVIES, S. P., Carling, D., & Hardie, D. G. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15185.x · Cited by 431 · see citing works
Calvert, J. W., Gundewar, S., Jha, S., Greer, J. J. M., Bestermann, W. H., Tian, R., & Lefer, D. J. (2008) · Diabetes · doi:10.2337/db07-1098 · Cited by 422 · see citing works
Purification and characterization of the AMP‐activated protein kinase
Carling, D., Clarke, P. R., Zammit, V. A., & Hardie, D. G. (1989) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1989.tb15186.x · Cited by 418 · see citing works
AMP-Activated Protein Kinase as a Drug Target
Hardie, D. G. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105304 · Cited by 405 · see citing works
McCabe, T. J., Fulton, D., Roman, L. J., & Sessa, W. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.9.6123 · Cited by 387 · see citing works
AMP-Activated Protein Kinase in the Heart
Arad, M., Seidman, C. E., & Seidman, J. G. (2007) · Circulation Research · doi:10.1161/01.res.0000258446.23525.37 · Cited by 356 · see citing works
Cheng, K. K. Y., Lam, K. S. L., Wang, Y., Huang, Y., Carling, D., Wu, D., Wong, C., & Xu, A. (2007) · Diabetes · doi:10.2337/db06-1580 · Cited by 318 · see citing works
Butt, E., Bernhardt, M., Smolenski, A., Kotsonis, P., Fröhlich, L. G., Sickmann, A., Meyer, H. E., Lohmann, S. M., & Schmidt, H. H. H. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.7.5179 · Cited by 284 · see citing works
Statins Activate AMP-Activated Protein Kinase In Vitro and In Vivo
Sun, W., Lee, T., Zhu, M., Gu, C., Wang, Y., Zhu, Y., & Shyy, J. Y.-J. (2006) · Circulation · doi:10.1161/circulationaha.106.630194 · Cited by 263 · see citing works
Bauer, P. M., Fulton, D. J., Boo, Y. C., Sorescu, G. P., Kemp, B. E., Jo, H., & Sessa, W. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211926200 · Cited by 243 · see citing works
ENDOTHELIAL-CARDIOMYOCYTE INTERACTIONS IN CARDIAC DEVELOPMENT AND REPAIR
Hsieh, P. C. H., Davis, M. E., Lisowski, L. K., & Lee, R. T. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124629 · Cited by 242 · see citing works
Shear stress stimulates phosphorylation of eNOS at Ser635by a protein kinase A-dependent mechanism
Boo, Y. C., Hwang, J., Sykes, M. C., Michell, B. J., Kemp, B. E., Lum, H., & Jo, H. (2002) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00214.2002 · Cited by 240 · see citing works
Michell, B. J., Harris, M. B., Chen, Z.-P., Ju, H., Venema, V. J., Blackstone, M. A., Huang, W., Venema, R. C., & Kemp, B. E. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205144200 · Cited by 212 · see citing works
Self-citationZhang, Y., Lee, T.-S., Kolb, E. M., Sun, K., Lu, X., Sladek, F. M., Kassab, G. S., Garland, T., & Shyy, J. Y.-J. (2006) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/01.atv.0000221230.08596.98 · Cited by 212 · see citing works
Agonist-modulated Regulation of AMP-activated Protein Kinase (AMPK) in Endothelial Cells
Levine, Y. C., Li, G. K., & Michel, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702182200 · Cited by 207 · see citing works
Erratum: Regulation of endothelium-derived nitric oxide production by the protein kinase Akt
Fulton, D. J., Gratton, J., McCabe, T. J. D., Fontana, J. T., Fujio, Y., Walsh, K., Franke, T. F., Papapetropoulos, A., & Sessa, W. C. (1999) · Nature · doi:10.1038/23523 · Cited by 204 · see citing works
Li, J., Hu, X., Selvakumar, P., Russell, R. R., Cushman, S. W., Holman, G. D., & Young, L. H. (2004) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00234.2004 · Cited by 197 · see citing works
Harris, M. B., Blackstone, M. A., Sood, S. G., Li, C., Goolsby, J. M., Venema, V. J., Kemp, B. E., & Venema, R. C. (2004) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00214.2004 · Cited by 117 · see citing works
Schulz, E., Anter, E., Zou, M., & Keaney, J. F. (2005) · Circulation · doi:10.1161/circulationaha.105.546812 · Cited by 114 · see citing works
Weekes, J., Ball, K. L., Caudwell, F. B., & Hardie, D. G. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)80706-z · Cited by 107 · see citing works
Boo, Y. C., Sorescu, G. P., Bauer, P. M., Fulton, D. J., Kemp, B. E., Harrison, D. G., Sessa, W. C., & Jo, H. (2003) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(03)00397-6 · Cited by 96 · see citing works
Lane, P. B., & Gross, S. S. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200258200 · Cited by 80 · see citing works
Omkumar, R. V., Darnay, B. G., & Rodwell, V. W. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)37448-3 · Cited by 74 · see citing works
Regulation of AMP‐activated protein kinase by a pseudosubstrate sequence on the γ subunit
Scott, J. W., Ross, F. A., Liu, J. K. D., & Hardie, D. G. (2007) · The EMBO Journal · doi:10.1038/sj.emboj.7601542 · Cited by 47 · see citing works
AMP-activated Protein Kinase Subunit Interactions
Iseli, T. J., Oakhill, J. S., Bailey, M. F., Wee, S., Walter, M., van Denderen, B. J., Castelli, L. A., Katsis, F., Witters, L. A., Stapleton, D., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m708298200 · Cited by 33 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Ungvari, Z., Tarantini, S., Donato, A. J., Galvan, V., & Csiszar, A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311378 · Cited by 919 · see citing works
Yuan, T., Yang, T., Chen, H., Fu, D., Hu, Y., Wang, J., Yuan, Q., Yu, H., Xu, W., & Xie, X. (2018) · Redox Biology · doi:10.1016/j.redox.2018.09.025 · Cited by 750 · see citing works
“AMPK stimulates release of NO in the vascular endothelial cells by phosphorylation of eNOS at Ser1177 and Ser633 [164] (Fig.”
BackgroundMechanisms of Dysfunction in the Aging Vasculature and Role in Age-Related Disease
Donato, A. J., Machin, D. R., & Lesniewski, L. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.312563 · Cited by 699 · see citing works
New Insight into Adiponectin Role in Obesity and Obesity-Related Diseases
Nigro, E., Scudiero, O., Monaco, M. L., Palmieri, A., Mazzarella, G., Costagliola, C., Bianco, A., & Daniele, A. (2014) · BioMed Research International · doi:10.1155/2014/658913 · Cited by 607 · see citing works
“The NO production, in physiologic condition, relaxes vessels and exerts anti-inflammation and antithrombotic effects on the vascular wall [92].”
BackgroundCellular and molecular biology of aging endothelial cells
Donato, A. J., Morgan, R. G., Walker, A. E., & Lesniewski, L. A. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.021 · Cited by 538 · see citing works
“AMPK activation also results in increased activation of eNOS [239, 240] via signaling through Rac1 and Akt [238, 240], as well as through direct phosphorylation of eNOS [241, 242].”
Molecular mechanisms underlying the activation of eNOS
Fleming, I. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0767-7 · Cited by 437 · see citing works
Effects of shear stress on endothelial cells: go with the flow
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · Acta Physiologica · doi:10.1111/apha.12725 · Cited by 434 · see citing works
AMPK inhibition in health and disease
Viollet, B., Horman, S., Leclerc, J., Lantier, L., Foretz, M., Billaud, M., Giri, S., & Andreelli, F. (2010) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2010.488215 · Cited by 383 · see citing works
“, 1999), Ser633 (Chen et al., 2009b) and by promoting its association with heat shock protein 90 (Davis et al.”
BackgroundWang, Q., Zhang, M., Torres, G., Wu, S., Ouyang, C., Xie, Z., & Zou, M.-H. (2017) · Diabetes · doi:10.2337/db16-0915 · Cited by 370 · see citing works
“For example, activation of AMPK-a1 or AMPK-a2 can improve endothelial function via directly phosphorylating eNOS at Ser1177 and Ser635 (46,47).”
BackgroundHsieh, H., Liu, C.-A., Huang, B., Tseng, A. H.-H., & Wang, D. L. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-3 · Cited by 333 · see citing works
“Studies with flow chamber module demonstrated that laminar flow triggered AMP-activated protein kinase (AMPK) activation and subsequent phosphorylation of eNOS at S635 and S1179 [43,44].”
BackgroundWang, S., Zhang, M., Liang, B., Xu, J., Xie, Z., Liu, C., Viollet, B., Yan, D., & Zou, M.-H. (2010) · Circulation Research · doi:10.1161/circresaha.109.212530 · Cited by 296 · see citing works
Activation and Signaling by the AMP-Activated Protein Kinase in Endothelial Cells
Fisslthaler, B., & Fleming, I. (2009) · Circulation Research · doi:10.1161/circresaha.109.201590 · Cited by 295 · see citing works
Cellular signaling and NO production
Michel, T. M., & Vanhoutte, P. M. (2010) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-009-0765-9 · Cited by 287 · see citing works
“AMPK can catalyze eNOS phosphorylation at ser 1177, yet AMPK is also the principal kinase that phosphorylates eNOS at ser 635 [8].”
BackgroundAdiponectin and cardiovascular health: an update
Hui, X. H., Lam, K. S., Vanhoutte, P. M., & Xu, A. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01395.x · Cited by 287 · see citing works
“Indeed, both globular and full-length adiponectin increase eNOS activity and NO production via AMPK-mediated phosphorylation of eNOS at Ser1177 (Chen et al., 2003) and Ser633 (Chen et al., 2009a) (Figure 3).”
BackgroundAMPK, Mitochondrial Function, and Cardiovascular Disease
Wu, S., & Zou, M.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21144987 · Cited by 286 · see citing works
“In response to several stimuli, including metformin [156], adiponectin [157], thrombin [158], histamine [159], berberine [160], ciglitazone [161], and vascular endothelial growth factor [162], AMPK is activated and in turn acts as a direct activator of eNOS by phosphorylating its Ser1177 residue [163].”
BackgroundShear stress, SIRT1, and vascular homeostasis
Chen, Z., Peng, I., Cui, X., Li, Y.-S. J., Chien, S., & Shyy, J. Y.-J. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1003833107 · Cited by 278 · see citing works
“We have shown that the application of laminar flow causes AMPK activation before SIRT1 elevation (22) (Fig.”
BackgroundMethodInfluentialDifferential Role of Leptin and Adiponectin in Cardiovascular System
Ghantous, C. M., Azrak, Z., Hanache, S., Abou-Kheir, W. G., & Zeidan, A. (2015) · International Journal of Endocrinology · doi:10.1155/2015/534320 · Cited by 203 · see citing works
“However, under pathological states, adiponectin inhibits iNOS and thus decreases NO release and promotes cardiac injury [141].”
BackgroundNitric Oxide: A Guardian for Vascular Grafts?
de Mel, A., Murad, F., & Seifalian, A. M. (2011) · Chemical Reviews · doi:10.1021/cr200008n · Cited by 187 · see citing works
Zhang, J., Dong, J., Martin, M., He, M., Gongol, B., Marin, T., Chen, L., Shi, X., Yin, Y., Shang, F., et al. (2018) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201712-2570oc · Cited by 186 · see citing works
“Such discrepancy is reminiscent of the selective AMPKa2 phosphorylation of eNOS and acetyl coenzyme A carboxylase in ECs (14).”
BackgroundSalt, I. P., & Hardie, D. G. (2017) · Circulation Research · doi:10.1161/circresaha.117.309633 · Cited by 186 · see citing works
AMPK, metabolism, and vascular function
Rodríguez, C., Muñoz, M., Contreras, C., & Prieto, D. (2021) · FEBS Journal · doi:10.1111/febs.15863 · Cited by 178 · see citing works
Koska, J., Sands, M., Burciu, C., D’Souza, K. M., Raravikar, K., Liu, J., Truran, S., Franco, D. A., Schwartz, E. A., Schwenke, D. C., et al. (2015) · Diabetes · doi:10.2337/db14-0976 · Cited by 174 · see citing works
“AMPK activation appeared to precede phosphorylation of eNOS, consistent with reports of this pathway sequence (43,44).”
ResultActivation of AMPK stimulates heme oxygenase-1 gene expression and human endothelial cell survival
Liu, X., Peyton, K. J., Shebib, A. R., Wang, H., Korthuis, R. J., & Durante, W. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00749.2010 · Cited by 170 · see citing works
Regulation of eNOS Enzyme Activity by Posttranslational Modification
Heiß, E. H., & Dirsch, V. M. (2014) · Current Pharmaceutical Design · doi:10.2174/13816128113196660745 · Cited by 167 · see citing works
“A similar cooperativity between AMPK and SIRT1 has also been observed for the transcriptional modulator peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1 α) [80].”
BackgroundInfluentialEffects of Metformin in Experimental Stroke
Li, J., Benashski, S. E., Venna, V. R., & McCullough, L. D. (2010) · Stroke · doi:10.1161/strokeaha.110.589697 · Cited by 172 · see citing works
Effects of AMP-Activated Protein Kinase in Cerebral Ischemia
Li, J., & McCullough, L. D. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2009.255 · Cited by 163 · see citing works
“The aorta of AMPK a2 knockout mice showed attenuated atorvastatin-induced eNOS phosphorylation (Chen et al, 2009b).”
BackgroundInfluentialOliveira‐Paula, G. H., Lacchini, R., & Tanus-Santos, J. E. (2015) · Gene · doi:10.1016/j.gene.2015.09.061 · Cited by 165 · see citing works
“In addition, NOS3 can be activated by phosphorylation at Ser633 mediated by AMPK (Chen et al., 2009).”
BackgroundRole of the energy sensor AMP-activated protein kinase in renal physiology and disease
Hallows, K. R., Mount, P. F., Pastor‐Soler, N. M., & Power, D. A. (2010) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00005.2010 · Cited by 156 · see citing works
“Activation of AMPK in endothelial cells has been reported in response to multiple and diverse stimuli, including shear stress (20), ATP depletion (95, 144), hormones such as adiponectin (18, 20, 99), bradykinin (96) and thrombin (116), the drugs metformin (143) and atorvastatin (20), and the free radical peroxynitrite…”
AMPK and NRF2: Interactive players in the same team for cellular homeostasis?
Petsouki, E., Cabrera, S. N. S., & Heiß, E. H. (2022) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2022.07.014 · Cited by 157 · see citing works
Yang, Q., Xu, J., Ma, Q., Liu, Z., Varadarajan, S., Cao, Y., Wang, L., Zeng, X., Zhou, Y., Zhang, M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-07132-x · Cited by 143 · see citing works
AMPK: A cellular metabolic and redox sensor. A minireview
Shirwany, N. A. (2014) · Frontiers in bioscience · doi:10.2741/4218 · Cited by 142 · see citing works
Wang, J., Alexanian, A., Ying, R., Kizhakekuttu, T. J., Dharmashankar, K., Vasquez-Vivar, J., Gutterman, D. D., & Widlansky, M. E. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.111.227389 · Cited by 134 · see citing works
“Furthermore, Spermine NONOate, an exogenous source of NO, reversed LG-induced mitochondrial hyperpolarization (P=0.97 vs. NG alone, P=0.007 vs. LG alone), while L-NAME significantly increased mitochondrial membrane potential in the setting of NG (P=0.004 vs. NG alone).”
InfluentialMarino, A., Hausenloy, D. J., Andreadou, I., Horman, S., Bertrand, L., & Beauloye, C. (2021) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2021.02.047 · Cited by 134 · see citing works
“It has been shown that AMPK activation, in response to ONOO , enhances eNOS and NO production to restore endothelial functions [70,131].”
BackgroundAdiponectin as a potential biomarker of vascular disease
Mohammadi, S., Arefhosseini, S. R., Ebrahimi‐Mameghani, M., Fallah, P., & Bazi, Z. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s48753 · Cited by 129 · see citing works
Eringa, E. C., Serné, E. H., Meijer, R. I., Schalkwijk, C. G., Houben, A. J. H. M., Stehouwer, C. D. A., Smulders, Y. M., & van Hinsbergh, V. W. M. (2013) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-013-9239-7 · Cited by 122 · see citing works
“AMPK regulates eNOS activity by phosphorylation at two serine residues, Ser 633 [94] and Ser 1177 [90, 95], and by stimulating the association of eNOS with heat-shock protein 90 [88].”
BackgroundAMPK in cardiovascular health and disease
Shirwany, N. A., & Zou, M. (2010) · Acta Pharmacologica Sinica · doi:10.1038/aps.2010.139 · Cited by 121 · see citing works
AMPK: a therapeutic target of heart failure—not only metabolism regulation
Li, X., Liu, J., Lü, Q., Ren, D., Sun, X., Rousselle, T. V., Tan, Y., & Li, J. (2018) · Bioscience Reports · doi:10.1042/bsr20181767 · Cited by 118 · see citing works
Regulation of NAD(P)H oxidases by AMPK in cardiovascular systems
Song, P., & Zou, M. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.01.025 · Cited by 119 · see citing works
Su, M., Zhao, W., Xu, S., & Weng, J. (2022) · Antioxidants · doi:10.3390/antiox11061085 · Cited by 120 · see citing works
AMPK-mediated regulation of transcription in skeletal muscle
McGee, S. L., & Hargreaves, M. (2010) · Clinical Science · doi:10.1042/cs20090533 · Cited by 111 · see citing works
Ewart, M., & Kennedy, S. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2010.11.002 · Cited by 110 · see citing works
AMP-Activated Protein Kinase and Metabolic Control
Viollet, B., & Andréelli, F. (2011) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-17214-4_13 · Cited by 106 · see citing works
Rutherford, C., Speirs, C., Williams, J. J. L., Ewart, M., Mancini, S. J., Hawley, S. A., Delles, C., Viollet, B., Costa‐Pereira, A. P., Baillie, G. S., et al. (2016) · Science Signaling · doi:10.1126/scisignal.aaf8566 · Cited by 105 · see citing works
“However other examples of AMPK substrates that only loosely follow the optimized consensus [such as Ser 633 in endothelial constitutive nitric oxide synthase (42) ] have also been documented.”
Hermida, N., & Balligand, J. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5537 · Cited by 105 · see citing works
“…AMPK is the only kinase identified to date that can potentially phosphorylate eNOS on more than one site, that is, on Ser1177 (29) and Ser633 (28), both activating sites in the reductase domain of the enzyme, leading to eNOS activation in endothelial cells and mouse aorta (169), although…”
Triggle, C. R., & Ding, H. (2015) · Acta Physiologica · doi:10.1111/apha.12644 · Cited by 99 · see citing works
“Published by John Wiley & Sons Ltd, doi: 10.1111/apha.12644 143 Ser1177 and Ser633 and enhances the generation of NO (Chen et al. 1999, 2009).”
BackgroundInfluentialSIRT1 Antagonizes Oxidative Stress in Diabetic Vascular Complication
Meng, T., Qin, W., & Liu, B. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.568861 · Cited by 99 · see citing works
“Except for SIRT1, AMPK has also been demonstrated to promote NO secretion by increasing eNOS phosphorylation as serine 633, which was another effective way for SIRT1 to overcome caloric restriction and facilitate vascular reconditioning after ischemia via activating the AMPK/eNOS axis (85, 86).”
BackgroundSong, L., Yang, Y.-J., Dong, Q., Qian, H., Gao, R.-L., Qiao, S.-B., Shen, R., He, Z.-X., Lu, M., Zhao, S., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0065702 · Cited by 98 · see citing works
“Chen et al have found low levels of Ator-induced eNOS phosphorylation in the aortas of AMPKa2 mice [34], suggesting that AMPKa is a primary kinase that phosphorylates eNOS.”
BackgroundStahmann, N., Woods, A., Spengler, K., Heslegrave, A., Bauer, R., Krause, S., Viollet, B., Carling, D., & Heller, R. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.108688 · Cited by 98 · see citing works
Endothelial nitric oxide synthase: A potential therapeutic target for cerebrovascular diseases
Zhu, J., Song, W., Li, L., & Fan, X. (2016) · Molecular Brain · doi:10.1186/s13041-016-0211-9 · Cited by 96 · see citing works
The Role of PPARγ in Cardiovascular Diseases
Kvandová, M., Majzúnová, M., & Dovinová, I. (2016) · Physiological Research · doi:10.33549/physiolres.933439 · Cited by 94 · see citing works
“…protein kinases, including PKA, PKB, PKC, AMPK, ERK and phosphatases such as protein phosphatase (PP)1 and S348 Kvandová et al. Vol. 65 PP2A in response to multiple stimuli via shear stress, growth factors, insulin, etc. (Fleming et al. 2001, Mount et al. 2007, Chen et al. 2009, Xiao et al. 2011).”
BackgroundTsai, K., Chen, L., Chiou, S., Chiou, G., Chen, Y., Chou, H., Chen, L., Chen, H., Chiu, T., Tsai, C., et al. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100147 · Cited by 93 · see citing works
Feng, Y., Zhang, Y., & Xiao, H. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9197-5 · Cited by 89 · see citing works
Lee, R. S., Ayala, J. E., Hunley, C. F., James, F. D., Bracy, D. P., Kang, L., & Wasserman, D. H. (2010) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00004.2010 · Cited by 87 · see citing works
“It has been suggested that the activation of AMPK is, in part, regulated by endogenous NO in a positive feedback mechanism, such that an increase in NO activates AMPK, which further augments NOS activity and NO production (8, 29, 50).”
BackgroundCheng, P., Ho, W., Su, Y., Lu, P., Chen, B., Cheng, W., Lu, W., Sun, G., Yeh, T., Hsiao, M., et al. (2014) · British Journal of Pharmacology · doi:10.1111/bph.12648 · Cited by 87 · see citing works
“H2O2-activated AMPK phosphorylates eNOS on serine 1177, but does not phosphorylate nNOS in cardiac myocytes (Sartoretto et al., 2011) and phosphorylates eNOS on serine 633 in vascular endothelial cells (Chen et al., 2009).”
BackgroundGarcía‐Prieto, C. F., Hernández-Nuño, F., Rio, D. D., Ruiz‐Hurtado, G., Aránguez, I., Ruiz‐Gayo, M., Somoza, B., & Fernández‐Alfonso, M. S. (2014) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400539 · Cited by 86 · see citing works
Mechanisms underlying blood pressure reduction by dietary inorganic nitrate
Carlström, M., Lundberg, J. O., & Weitzberg, E. (2018) · Acta Physiologica · doi:10.1111/apha.13080 · Cited by 86 · see citing works
“Nitrite and nitrate can activate this important regulator of cellular energy homeostasis,(196,197) which in turn may activate eNOS by stimulating enzyme phosphorylation.(198) As AMPK is deeply involved in regulating glucose metabolism and cellular energetics, its activation by nitrate and nitrite may also explain the…”
BackgroundHydrogen peroxide differentially modulates cardiac myocyte nitric oxide synthesis
Sartoretto, J. L., Kalwa, H., Pluth, M. D., Lippard, S. J., & Michel, T. M. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111331108 · Cited by 84 · see citing works
“11), including the AMP-activated protein kinase (AMPK), which phosphorylates the enzyme on serine 1177 in cardiac myocytes (12) and on serine 633 in vascular endothelial cells (13).”
BackgroundFish oil and vascular endothelial protection: Bench to bedside
Balakumar, P., & Taneja, G. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2012.05.005 · Cited by 81 · see citing works
Perivascular fat, AMP ‐activated protein kinase and vascular diseases
Almabrouk, T. A. M., Ewart, M., Salt, I. P., & Kennedy, S. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12479 · Cited by 80 · see citing works
“In the vasculature, activation of endothelial AMPK has been shown to phosphorylate eNOS at Ser1177 and Ser633, stimulating NO release (Chen et al., 2009; Mariman and Wang, 2010) and subsequent vasodilatation of both large conduit and resistance blood vessels (Wang et al., 2009b; Bradley et al.,…”
BackgroundBalakumar, P., & Kathuria, S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01938.x · Cited by 78 · see citing works
“…kinase (AMPK) and ERK, and phosphatases such as protein phosphatase (PP)1 and PP2A in response to multiple stimuli via shear stress, growth factors, insulin, etc. (Dimmeler et al., 1999; Michell et al., 1999; 2001; Fleming et al., 2001; Mount et al., 2007; Chen et al., 2009; Xiao et al., 2011).”
BackgroundInfluentialStatins in neurological disorders: An overview and update
Malfitano, A. M., Marasco, G., Proto, M., Laezza, C., Gazzerro, P., & Bifulco, M. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.06.007 · Cited by 78 · see citing works
“[31] Chen Z, Peng IC, Sun W, Su MI, Hsu PH, Fu Y, et al.”
BackgroundCalcitonin gene-related peptide promotes angiogenesis via AMP-activated protein kinase
Zheng, S., Li, W., Xu, M., Bai, X., Zhou, Z., Han, J., Shyy, J. Y.-J., & Wang, X. (2010) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00173.2010 · Cited by 79 · see citing works
“Since AMPK phosphorylates eNOS at both Ser-633 and Ser-1177 to enhance the eNOS-derived NO bioavailability (5), we then studied whether CGRP can increase the eNOS phosphorylation, and if so, whether this activation is mediated through AMPK.”
BackgroundImmunometabolism of AMPK in insulin resistance and atherosclerosis
Fullerton, M. D., Steinberg, G. R., & Schertzer, J. D. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.02.004 · Cited by 73 · see citing works
Antonopoulos, A. S., Margaritis, M., Shirodaria, C. C., & Antoniades, C. A. (2012) · Thrombosis and Haemostasis · doi:10.1160/th12-05-0337 · Cited by 73 · see citing works
“In endothelial cells simvastatin induces eNOS Ser633 phosphorylation in an AMP-activated protein kinase (AMPK)-mediated way (37).”
BackgroundWang, P., Wang, S. C., Yang, H.-P., Lv, C., Jia, S., Liu, X., Wang, X., Meng, D., Qin, D., Zhu, H. F., et al. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00454 · Cited by 73 · see citing works
How do Uremic Toxins Affect the Endothelium?
da Cunha, R. S., Santos, A. F., Barreto, F. C., & Stinghen, A. E. M. (2020) · Toxins · doi:10.3390/toxins12060412 · Cited by 72 · see citing works
“functions, including the production of nitric oxide (NO), vasodilation, and permeability [15,16].”
BackgroundSchuhmacher, S., Foretz, M., Knorr, M., Jansen, T., Hortmann, M., Wenzel, P., Oelze, M. W., Kleschyov, A. L., Daiber, A., Keaney, J. F., et al. (2011) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.110.219543 · Cited by 71 · see citing works
Asiatic Acid Protects against Cardiac Hypertrophy through Activating AMPKα Signalling Pathway
Ma, Z., Dai, J., Wei, W., Zhang, W.-B., Xu, S., Liao, H.-H., Yang, Z., & Tang, Q. (2016) · International Journal of Biological Sciences · doi:10.7150/ijbs.14213 · Cited by 71 · see citing works
“Previous report indicated that AA alleviated cardiovascular remodeling in rats with hypertension via restoration of eNOS expression, which has been proven a direct target of AMPKα [16, 29].”
Adipokines and the cardiovascular system: mechanisms mediating health and disease
Northcott, J. M., Yeganeh, A., Taylor, C. G., Zahradka, P. C., & Wigle, J. T. (2012) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y2012-053 · Cited by 70 · see citing works
Ford, R. J., Teschke, S. R., Reid, E. B., Durham, K. K., Kroetsch, J. T., & Rush, J. W. E. (2012) · Journal of Hypertension · doi:10.1097/hjh.0b013e32835050ca · Cited by 70 · see citing works
“Mechanisms suggested in other work that could account for enhanced nitric oxide bioavailability or bioactivity with AMPK activation include phosphorylation of eNOS activation site Ser633 [14], formation of active eNOS complexes [12,15], increased sensitivity of downstream signaling mechanisms, or other yet unidentifie…”
BackgroundEnkhjargal, B., Godo, S., Sawada, A., Nergui, S., Saito, H., Noda, K., Satoh, K., & Shimokawa, H. (2014) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.114.303735 · Cited by 70 · see citing works
“As a metabolic sensor, eAMPK plays an important role in metabolic regulation of blood flow,(24,26) which is also regulated by endothelial NO synthase (eNOS)(27,28) through AMPK activation.(29,30) However, the role of eAMPK in EDH remains to be elucidated.”
BackgroundRossoni, L. V., Wareing, M., Wenceslau, C. F., Al‐Abri, M., Cobb, C., & Austin, C. E. (2011) · Clinical Science · doi:10.1042/cs20110259 · Cited by 69 · see citing works
Li, X.-D., Yang, Y.-J., Geng, Y., Chen, J., Hu, F., Zhao, J.-L., Zhang, H.-T., Cheng, Y.-T., Qian, H., Wang, L., et al. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00459.2010 · Cited by 69 · see citing works
“Previous studies have found that the phosphorylation of Ser 1179, regulated by the PKA and PI3K/Akt pathways, is pivotal for eNOS activation in response to shear stress, adiponectin, and statins (6, 10, 11), whereas the phosphorylation of Ser, mainly activated by PKA and AMPK (2, 4, 7), is the most potent in stimulati…”
BackgroundInfluentialJansen, T., Kvandová, M., Daiber, A., Stamm, P., Frenis, K., Schulz, E., Münzel, T., & Kröller-Schön, S. (2020) · Antioxidants · doi:10.3390/antiox9060525 · Cited by 68 · see citing works
“Endothelium-derived NO is the key player in the regulation of the vascular tone [74,75].”
BackgroundRodríguez, C., Contreras, C., Medina, J. S., Muñoz, M., Corbacho, C., Carballido, J., García‐Sacristán, A., Hernández, M., López, M., Rivera, L., et al. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101575 · Cited by 68 · see citing works
“response to physiological stimuli such as shear stress [7,11,12] or adipokines acting via Gq receptors like adiponectin and leptin [1].”
BackgroundPsefteli, P., Kitscha, P., Vizcay‐Barrena, G., Fleck, R. A., Chapple, S. J., Mann, G. E., Fowler, M. I., & Siow, R. C. M. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101816 · Cited by 67 · see citing works
“6A and B) which are critical for NO output [52, 53].”
BackgroundProtective effects of AMP‐activated protein kinase in the cardiovascular system
Xu, Q., & Si, L. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01179.x · Cited by 67 · see citing works
“Journal compilation © 2010 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd Ser633, was identified; the authors confirmed that AMPK phosphorylation of eNOS Ser633 is a functional signalling event contributing to nitric oxide bioavailability in endothelial cells [71].”
BackgroundPPARδ Activation Protects Endothelial Function in Diabetic Mice
Tian, X. Y., Wong, W. T., Wang, N., Lu, Y., Cheang, W. S., Liu, J., Liu, L., Liu, Y., Lee, S. S. T., Chen, Z., et al. (2012) · Diabetes · doi:10.2337/db12-0117 · Cited by 67 · see citing works
“negative Akt (Ad-DN-Akt) was described previously (33).”
Mackenzie, R. M., Salt, I. P., Miller, W. H., Logan, A., Ibrahim, H., Degasperi, A., Dymott, J. A., Hamilton, C. A., Murphy, M. P., Delles, C., et al. (2012) · Clinical Science · doi:10.1042/cs20120239 · Cited by 67 · see citing works
The role of endothelial mechanosensitive genes in atherosclerosis and omics approaches
Simmons, R. D., Kumar, S., & Jo, H. (2015) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2015.11.005 · Cited by 67 · see citing works
Cardiovascular impact of drugs used in the treatment of diabetes
Triggle, C. R., & Ding, H. (2014) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314546125 · Cited by 66 · see citing works
“Activation of AMPK might also be a contributing factor to the beneficial effects of metformin on the endothelium as AMPK also phosphorylates and activates eNOS [Chen et al. 2009].”
BackgroundCui, X., Liu, X., Feng, H., Zhao, S., & Gao, H. (2012) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b12-00598 · Cited by 66 · see citing works
Siragusa, M., Justo, A. F. O., Malacarne, P. F., Strano, A., Buch, A., Withers, B., Peters, K. G., & Fleming, I. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa213 · Cited by 66 · see citing works
Tissue-specific role and associated downstream signaling pathways of adiponectin
Roy, B., & Palaniyandi, S. S. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00587-4 · Cited by 65 · see citing works
“Chen Z, et al. AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633.”
BackgroundChatauret, N. P., Coudroy, R., Delpech, P., Vandebrouck, C., Hosni, S., Scépi, M., & Hauet, T. (2014) · American Journal of Transplantation · doi:10.1111/ajt.12904 · Cited by 64 · see citing works
Sowers, J. R., Habibi, J., Aroor, A. R., Yang, Y., Lastra, G., Hill, M. A., Whaley‐Connell, A. T., Jaisser, F., & Jia, G. (2019) · Metabolism · doi:10.1016/j.metabol.2019.153946 · Cited by 63 · see citing works
“Indeed, AMPKα activation is necessary for phosphorylation and optimal activation of eNOS [16], and Sirt1 promotes phosphorylation/activation of eNOS through deacetylating lysine 496 and 506 [17].”
BackgroundHwang, Y. P., Kim, H. G., Hiền, T. T., Jeong, M. H., Jeong, T. C., & Jeong, H. G. (2011) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2011.08.017 · Cited by 62 · see citing works
Back to the heart: The protective role of adiponectin
Caselli, C., D’Amico, A., Cabiati, M., Prescimone, T., Ry, S. D., & Giannessi, D. (2014) · Pharmacological Research · doi:10.1016/j.phrs.2014.03.003 · Cited by 61 · see citing works
Ducsay, C. A., & Myers, D. A. (2011) · Journal of Endocrinology · doi:10.1530/joe-11-0034 · Cited by 59 · see citing works
“Recently, Chen et al. (2009) showed that AMPK phosphorylates eNOS at Ser633 and is a functional signal of NO bioavailability.”
BackgroundTargeting the NO/superoxide ratio in adipose tissue: relevance to obesity and diabetes management
Janković, A., Korać, A., Buzadžić, B., Stančić, A., Otašević, V., Ferdinándy, P., Daiber, A., & Korać, B. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13498 · Cited by 60 · see citing works
“In endothelial cells, AMPK activates eNOS via phosphorylation at Ser1177 and Ser633 (Chen et al., 1999, 2009).”
BackgroundWang, X., Song, S., Xiao, H., Gao, P., Li, X.-J., & Si, L. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000363031 · Cited by 58 · see citing works
VEGF Triggers Transient Induction of Autophagy in Endothelial Cells via AMPKα1
Spengler, K., Kryeziu, N., Größe, S., Mosig, A. S., & Heller, R. (2020) · Cells · doi:10.3390/cells9030687 · Cited by 58 · see citing works
Teng, R., Du, J., Afolayan, A. J., Eis, A., Shi, Y., & Konduri, G. G. (2012) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00200.2012 · Cited by 54 · see citing works
“Increased ROS formation has been shown to activate AMPK (52, 53) in some vascular beds, which may increase the activity of eNOS (5, 6) and antioxidant 0 2 4 6 8 10 12 14”
BackgroundChing, L., Chen, C., Su, K., Hou, H., Shyue, S., Kou, Y. R., & Lee, T. (2012) · Molecular Medicine · doi:10.2119/molmed.2011.00461 · Cited by 54 · see citing works
“These findings are in line with previous findings that AMPK functionally phosphorylates eNOS at Ser635 and Ser1179 in ECs and subsequently promotes NO bioavailability in ECs (27,28).”
BackgroundResultFord, R. J., & Rush, J. W. E. (2010) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00597.2010 · Cited by 53 · see citing works
“A number of cell culture and in vitro biochemical experiments have demonstrated that AMPK can phosphorylate eNOS at activation site Ser(1177) (5, 6, 8, 12, 29, 40) and that AMPK activation has been associated with increased NO release from endothelial cells (5, 8, 12, 40), establishing NO as a potential mediator of en…”
BackgroundInfluentialEffects of exercise training and resveratrol on vascular health in aging
Gliemann, L., Nyberg, M., & Hellsten, Y. (2016) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2016.03.037 · Cited by 53 · see citing works
Dose dependent effects of cadmium on tumor angiogenesis
Wei, T., Jia, J., Wada, Y., Kapron, C. M., & Liu, J. (2017) · Oncotarget · doi:10.18632/oncotarget.16572 · Cited by 51 · see citing works
“Phosphorylation of eNOS leads to a flux of electrons through its reductase domain and thus facilitates the oxidative reaction in which L-arginine is transformed to L-citrulline and NO [48, 54-57].”
BackgroundDuan, Q., Song, P., Ye, D., & Zou, M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13833 · Cited by 50 · see citing works
“This has been mechanistically attributed to the higher NO release by enhancing the phosphorylation and activation of endothelial NOS (eNOS) at Ser1177 and Ser633 (Chen et al., 2009; Zhang et al., 2009b) and by blocking NO inactivation by reactive oxygen species (Deng et al., 2010).”
BackgroundMuscle Insulin Resistance and the Inflamed Microvasculature: Fire from Within
Liu, J., & Liu, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030562 · Cited by 48 · see citing works
“AMPK can functionally phosphorylate eNOS on multiple sites including Ser633 and Ser1177 to increase endothelial NO production [72,73] Activation of AMPK in addition to regulating NO production also regulates mitochondrial function and substrate metabolism as well as inhibits oxidative stress, ER stress and inflammatio…”
BackgroundAMPK α2 subunit is involved in platelet signaling, clot retraction, and thrombus stability
Randriamboavonjy, V., Isaak, J., Frömel, T., Viollet, B., Fißlthaler, B., Preissner, K. T., & Fleming, I. (2010) · Blood · doi:10.1182/blood-2010-04-279612 · Cited by 47 · see citing works
- Authors
- Chen, Z., Peng, I.-C., Sun, W., Su, M.-I., Hsu, P.-H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.-D., & Shyy, J. Y.-J.
- Affiliations
- University of California, Riverside (US)
- Venue
- Circulation Research
- Published
- 2009-02-27
- Volume
- 104
- Issue
- 4
- Pages
- 496-505
- ISSN
- 0009-7330 (ISSN-L)
- 1524-4571
- PMC
- PMC2761102
- OpenAlex
- W1966733021
- Cited by
- 264
- References
- 46
- Citations by year
- 2026: 8 · 2025: 6 · 2024: 8 · 2023: 6 · 2022: 10 · 2021: 17 · 2020: 19 · 2019: 12 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 22 · 2014: 27 · 2013: 15 · 2012: 26
- FWCI
- 16.35
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Circulation Research (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (HL-77448, R01HL089940, R01HL077448, HL89940)
- National Institute of General Medical Sciences (R01GM066151)
- Topics
- Health Sciences › Medicine › Physiology › Nitric Oxide and Endothelin Effects
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- AMPK, endothelial nitric oxide synthase, eNOS Ser1177 phosphorylation, nitric oxide bioavailability, shear stress, atorvastatin, adiponectin, AMPKα2, vascular endothelial cells, post-translational modification, AICAR
- MeSH terms
- Atorvastatin, Acetyl-CoA Carboxylase, Aminoimidazole Carboxamide, Animals, Cattle, Cells, Cultured, Chromatography, Liquid, Enzyme Activation, Heptanoic Acids, Humans, Mice, Inbred C57BL, Mutation, Nitric Oxide, Phosphorylation, Protein Processing, Post-Translational, Pyrazoles, Pyrimidines, Pyrroles, Ribonucleotides, Serine, Stress, Mechanical, Time Factors, Transfection, Signal Transduction, Mice, Knockout, Hydroxymethylglutaryl-CoA Reductase Inhibitors, RNA Interference, RNA, Small Interfering, Nanotechnology, Endothelial Cells, Protein Kinase Inhibitors, Mice, Adiponectin, Nitric Oxide Synthase Type III, Tandem Mass Spectrometry, AMP-Activated Protein Kinases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review